{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:35:55Z","timestamp":1795041355032,"version":"4.10.2"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Tertiary lymphoid structures (TLS), ordered structure of tumor-infiltrating immune cells in tumor immune microenvironment (TIME), play an important role in the development and anti-tumor immunity of various cancers, including liver, colon, and gastric cancers. Previous studies have demonstrated that the presence of TLS in intra-tumoral (IT), invasive margin (IM), and peri-tumoral (PT) regions of the tumors at various maturity statuses. However, the density of TLS in different regions of non-small cell lung cancer (NSCLC) has not been extensively studied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>TLS and tumor-infiltrating immune cells were assessed using immunohistochemistry (IHC) staining in 82 NSCLC patients. Tumor samples were divided into three subregions as IT, IM and PT regions, and TLS were identified as early\/primary TLS (E-TLS) or secondary\/follicular TLS (F-TLS). The distribution of TLS in different maturity statuses, along with their correlation with clinicopathological characteristics and prognostic value, was assessed. Nomograms were used to predict the probability of 1-, 3-, and 5-year overall survival (OS) in patients with NSCLC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The density of TLS and proportion of F-TLS in the IT region (90.2%, 0.45\/mm<jats:sup>2<\/jats:sup>, and 61.0%, respectively) were significantly higher than those in the IM region (72.0%, 0.18\/mm<jats:sup>2<\/jats:sup>, and 39.0%, respectively) and PT region (67.1%, 0.16\/mm<jats:sup>2<\/jats:sup>, and 40.2%, respectively). A lower density of TLS, especially E-TLS in the IM region, was correlated with better prognosis in NSCLC patients. CD20+ B cells, CD3+ T cells, CD8+ cytotoxic T cells, and CD68+ macrophages were significantly overexpressed in the IM region. CD20+ B cells and CD3+ T cells in the IM region were significantly correlated with the density of E-TLS, while no statistically significant correlation was found with F-TLS. The E-TLS density in the IM region and TNM stage were independent prognostic factors for NSCLC patients. The nomogram showed good prognostic ability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A higher density of E-TLS in the IM region was associated with a worse prognosis in NSCLC patients, potentially due to the inhibition of TLS maturation caused by the increased density of suppressive immune cells at the tumor invasion front.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1423775","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T22:44:13Z","timestamp":1723761853000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer"],"prefix":"10.3389","volume":"15","author":[{"given":"Shuyue","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.12.655","article-title":"Distribution, risk factors, and temporal trends for lung cancer incidence and mortality: A global analysis","volume":"161","author":"Huang","year":"2022","journal-title":"Chest"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02828-w","article-title":"Immunotherapy response modeling by ex-vivo organ culture for lung cancer","volume":"70","author":"Kamer","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00258","article-title":"Inducible bronchus-associated lymphoid tissue: taming inflammation in the lung","volume":"7","author":"Hwang","year":"2016","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2020_218","article-title":"Basics of inducible lymphoid organs","volume":"426","author":"Ruddle","year":"2020","journal-title":"Curr Top Microbiol Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12405","article-title":"Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers","volume":"271","author":"Dieu-Nosjean","year":"2016","journal-title":"Immunol Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626776","article-title":"Tertiary lymphoid structure-B cells narrow regulatory T cells impact in lung cancer patients","volume":"12","author":"Germain","year":"2021","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1900508","article-title":"Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies","volume":"10","author":"Jacquelot","year":"2021","journal-title":"Oncoimmunology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.06.023","article-title":"Pancreatic cancer chemotherapy is potentiated by induction of tertiary lymphoid structures in mice","volume":"12","author":"Delvecchio","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.788640","article-title":"Combination of tertiary lymphoid structure and neutrophil-to-lymphocyte ratio predicts survival in patients with hepatocellular carcinoma","volume":"12","author":"Wen","year":"2021","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1378844","article-title":"Maturation of tertiary lymphoid structures and recurrence of stage ii and iii colorectal cancer","volume":"7","author":"Posch","year":"2018","journal-title":"Oncoimmunology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1900635","article-title":"Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer","volume":"10","author":"JG","year":"2021","journal-title":"Oncoimmunology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001188","article-title":"Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors","volume":"8","author":"Zhang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-03067-3","article-title":"The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: A single-center, retrospective study","volume":"71","author":"Fukuhara","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Sili\u0146a","year":"2018","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13389","article-title":"Oral cancer-associated tertiary lymphoid structures: gene expression profile and prognostic value","volume":"199","author":"Li","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3290","article-title":"Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma","volume":"16","author":"Finkin","year":"2015","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.648812","article-title":"Peritumoral tertiary lymphoid structures correlate with protective immunity and improved prognosis in patients with hepatocellular carcinoma","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.04.011","article-title":"Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas","volume":"31","author":"Derks","year":"2020","journal-title":"Ann Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1186\/s12885-022-09777-w","article-title":"Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma","volume":"22","author":"Deguchi","year":"2022","journal-title":"BMC Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cell.2022.12.028","article-title":"Multiplexed 3d atlas of state transitions and immune interaction in colorectal cancer","volume":"186","author":"Lin","year":"2023","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003773","article-title":"Genomic profiles and their associations with tmb, pd-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers","volume":"9","author":"Hu","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101703","article-title":"Activation of B cells in tertiary lymphoid structures in cancer: anti-tumor or anti-self","volume":"65","author":"Fridman","year":"2023","journal-title":"Semin Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02407-8","article-title":"The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer","volume":"68","author":"Sofopoulos","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.03.019","article-title":"Egfr Oncogenic Mutations in Nsclc Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion through up-Regulation of Cd47","volume":"19","author":"Hu","year":"2024","journal-title":"J Thorac Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/diagnostics13010052","article-title":"Prognostic utility of cd47 in cancer of the uterine cervix and the sensitivity of immunohistochemical scores","volume":"13","author":"Yordanov","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05771-9","article-title":"Antibodies against endogenous retroviruses promote lung cancer immunotherapy","volume":"616","author":"Ng","year":"2023","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5731","article-title":"Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma","volume":"12","author":"Xu","year":"2023","journal-title":"Cancer Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.877689","article-title":"Tumor-resident T cells, associated with tertiary lymphoid structure maturity, improve survival in patients with stage iii lung adenocarcinoma","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0952","article-title":"Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer","volume":"71","author":"de Chaisemartin","year":"2011","journal-title":"Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1051922","article-title":"A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased cd4(+) T cell receptor repertoire clonality","volume":"4","author":"Zhu","year":"2015","journal-title":"Oncoimmunology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.annonc.2021.09.021","article-title":"Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer","volume":"33","author":"Federico","year":"2022","journal-title":"Ann Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-220","article-title":"The number and microlocalization of tumor-associated immune cells are associated with patient\u2019s survival time in non-small cell lung cancer","volume":"10","author":"Dai","year":"2010","journal-title":"BMC Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01853-y","article-title":"A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma","volume":"40","author":"Wu","year":"2021","journal-title":"Oncogene"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1882743","article-title":"B-cell clusters at the invasive margin associate with longer survival in early-stage oral-tongue cancer patients","volume":"10","author":"Phanthunane","year":"2021","journal-title":"Oncoimmunology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"19997","DOI":"10.1038\/s41598-019-56441-8","article-title":"The prognostic importance of cd20(+) B lymphocytes in colorectal cancer and the relation to other immune cell subsets","volume":"9","author":"Edin","year":"2019","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.794217","article-title":"Case report: sarcoid-like reactions and tertiary lymphoid structures following dual checkpoint inhibition in a patient with early-stage lung adenocarcinoma","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2929","article-title":"Early hepatic lesions display immature tertiary lymphoid structures and show elevated expression of immune inhibitory and immunosuppressive molecules","volume":"26","author":"Meylan","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-012017-043208","article-title":"Cd8 T cell exhaustion in chronic infection and cancer: opportunities for interventions","volume":"69","author":"Hashimoto","year":"2018","journal-title":"Annu Rev Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00018","article-title":"Advances in anti-tumor treatments targeting the cd47\/sirp\u03b1 Axis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13045-021-01197-w","article-title":"Targeting cd47 for cancer immunotherapy","volume":"14","author":"Jiang","year":"2021","journal-title":"J Hematol Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1423775\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T22:44:17Z","timestamp":1723761857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1423775\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2024.1423775"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1423775","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2024.1423775.s001","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"article-number":"1423775"}}